BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33602047)

  • 41. Long-term mortality benefit of renin-angiotensin system inhibitors in patients with chronic limb-threatening ischemia undergoing vascular intervention.
    Bodewes TCF; Darling JD; O'Donnell TFX; Deery SE; Shean KE; Mittleman MA; Moll FL; Schermerhorn ML
    J Vasc Surg; 2018 Mar; 67(3):800-808.e1. PubMed ID: 29079009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of major adverse lower limb events in patients with tissue loss secondary to critical limb-threatening ischemia.
    Vosgin-Dinclaux V; Bertucat P; Dari L; Webster C; Foussard N; Mohammedi K; Ducasse E; Caradu C
    Cardiovasc Revasc Med; 2024 Jul; 64():34-41. PubMed ID: 38350775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass.
    Nolan BW; De Martino RR; Stone DH; Schanzer A; Goodney PP; Walsh DW; Cronenwett JL;
    J Vasc Surg; 2011 Sep; 54(3):730-5; discussion 735-6. PubMed ID: 21802888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery disease.
    Kim TI; Zhang Y; Cardella JA; Guzman RJ; Ochoa Chaar CI
    J Vasc Surg; 2021 Dec; 74(6):1968-1977.e3. PubMed ID: 34090986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of ambulatory status on outcomes of percutaneous vascular interventions and lower extremity bypass for critical limb ischemia in the Vascular Quality Initiative.
    Lu K; Farber A; Schermerhorn ML; Patel VI; Kalish JA; Rybin D; Doros G; Siracuse JJ
    J Vasc Surg; 2017 Jun; 65(6):1706-1712. PubMed ID: 28216361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bypass versus endovascular intervention for healing ischemic foot wounds secondary to tibial arterial disease.
    Mohapatra A; Henry JC; Avgerinos ED; Boitet A; Chaer RA; Makaroun MS; Leers SA; Hager ES
    J Vasc Surg; 2018 Jul; 68(1):168-175. PubMed ID: 29336904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Global Vascular Guidelines-Based Bypass-Preferred Population and Their Surgical Risk Among CLTI Patients Treated With Endovascular Therapy in a Real-World Practice.
    Okamoto S; Iida O; Takahara M; Hata Y; Asai M; Masuda M; Ishihara T; Nanto K; Kanda T; Tsujimura T; Okuno S; Matsuda Y; Mano T
    J Endovasc Ther; 2020 Aug; 27(4):608-613. PubMed ID: 32419595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative.
    Siracuse JJ; Menard MT; Eslami MH; Kalish JA; Robinson WP; Eberhardt RT; Hamburg NM; Farber A;
    J Vasc Surg; 2016 Apr; 63(4):958-65.e1. PubMed ID: 26830690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia between patients with and without diabetes.
    Darling JD; Bodewes TCF; Deery SE; Guzman RJ; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
    J Vasc Surg; 2018 Apr; 67(4):1159-1169. PubMed ID: 28947228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative.
    Cleman J; Romain G; Grubman S; Guzman RJ; Smolderen KG; Mena-Hurtado C
    J Vasc Surg; 2023 Sep; 78(3):745-753.e6. PubMed ID: 37207790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative.
    Singh N; Zeng C; Lewinger JP; Wolfson AM; Shavelle D; Weaver F; Garg PK
    J Vasc Surg; 2019 Oct; 70(4):1225-1234.e1. PubMed ID: 30852042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limb-Based Patency After Surgical vs Endovascular Revascularization in Patients with Chronic Limb-Threatening Ischemia.
    Utsunomiya M; Takahara M; Iida O; Soga Y; Hata Y; Shiraki T; Nagae A; Kato T; Kobayashi N; Suematsu N; Tasaki J; Horie K; Uchida D; Kodama A; Azuma N; Nakamura M
    J Endovasc Ther; 2020 Aug; 27(4):584-594. PubMed ID: 32431246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Racial and ethnic disparities in 3-year outcomes following infrainguinal bypass for chronic limb-threatening ischemia.
    Anjorin AC; Marcaccio CL; Patel PB; Wang SX; Rowe V; Aulivola B; Wyers MC; Schermerhorn ML
    J Vasc Surg; 2022 Nov; 76(5):1335-1346.e7. PubMed ID: 35768062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
    Desai K; Han B; Kuziez L; Yan Y; Zayed MA
    J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endovascular Versus Surgical Revascularization for Acute Limb Ischemia: A Propensity-Score Matched Analysis.
    Kolte D; Kennedy KF; Shishehbor MH; Mamdani ST; Stangenberg L; Hyder ON; Soukas P; Aronow HD
    Circ Cardiovasc Interv; 2020 Jan; 13(1):e008150. PubMed ID: 31948292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).
    Meecham L; Popplewell M; Bate G; Patel S; Bradbury AW
    J Vasc Surg; 2019 Jun; 69(6):1840-1847. PubMed ID: 30852037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-intensity statin therapy reduces risk of amputation and reintervention among patients undergoing lower extremity bypass for chronic limb-threatening ischemia.
    He JJ; Horns JJ; Kraiss LW; Smith BK; Griffin CL; DeMartino RR; Sarfati MR; Brooke BS
    J Vasc Surg; 2023 Feb; 77(2):497-505. PubMed ID: 36115522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations.
    Darling JD; McCallum JC; Soden PA; Guzman RJ; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
    J Vasc Surg; 2017 Mar; 65(3):695-704. PubMed ID: 28073665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Propensity score analysis of clinical outcome after bypass surgery vs. endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia.
    Soga Y; Mii S; Iida O; Okazaki J; Kuma S; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Kamoi D; Shintani Y
    J Endovasc Ther; 2014 Apr; 21(2):243-53. PubMed ID: 24754284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early evaluation of the infrainguinal revascularization strategy selection tool of the Global Vascular Guidelines for chronic limb-threatening ischemia patients.
    Haga M; Shindo S; Motohashi S; Nishiyama A; Kimura M; Inoue H; Akasaka J
    J Vasc Surg; 2021 Oct; 74(4):1253-1260.e2. PubMed ID: 33940070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.